Nevertheless, this study provides preliminary evidence that potentially unfavorable combinations of polymorphisms from the HMGB1/RAGE axis could synergistically affect the onset and progression of hepatocellular carcinoma. This evidence concerns the gene AGER and hepatocellular carcinoma.